I see with IG that the shorters are now 4%, am pretty sure it was 2% last week. Anyone able to get numbers for other providers Interactive Investors and AJ Bell so we can monitor? Will only give us a small idea granted.
I echo what has been said and John 4242 that comment was over the top and not warranted. I am in another stock SAR that has gone up over 100% in the last month and that has dragged in the day traders/rampers/derampers et al that has changed what was a good, informative board.
I like reading DJ’s and Wasa’s ramblings when I have the time. In other circumstances will skirt past just looking for nuggets on HZM or the many postings on the nickel market. It is very easy to move on past a post if it’s a topic you aren’t interested in my opinion.
Now Jezza get a move on son and get finance sorted please!
Hi John, am holding strong on HZM. Just hope finance gets sorted soon so we can be mining within 2 years. I will not top slice any until 20p, guess that will need finance plus news on Vermelho plus offtakes etc. Am happy to sit on my hands with this as well as SAR.
I think…without evidence…it’s being forward sold by one of the II’s ahead of finance. The worrying thing if they are selling here does it mean that the last bit of finance will be done around 6.5/6.75p? If so that is disappointing for long term holders but also for the institutions that partook at 7.5p I guess.
There is going to be a nickel shortage for the EV market by 2025/26 is the forecast. Araguaia will be first on stream but that’s for the stainless steel market hopefully by 2024. HZM will, in my opinion and also of Jeremy Martin, the CEO be unable to run both. Therefore for Vermelho, the jewel in the crown as it can supply nickel for the EV market, it looks likely being a JV. There will be lots of companies looking at this asset but all eyes on the DFS to be completed soon. Lots to love but more money to be made when in production IMO.
Hi Xv, the SAR board has some great posters with great medical and molecular knowledge like Toth. SAR have a range of molecules which will hopefully work in COVID, immunotherapy and cancer so no one trick pony. News is waiting on entry in Agile but other news can drop any time also. Nobody likes buying at the top but all loose shares are being hoovered up at mom.I am in for the long haul on this one as COVID news would be a bonus but not an exit for me, Cheers.